Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria
AN Gordon-Weeks, A Snaith, T Petrinic… - Journal of British …, 2011 - academic.oup.com
Background The aim of this systematic review was to assess the evidence on tumour
downstaging before liver transplantation in patients with hepatocellular carcinoma (HCC) …
downstaging before liver transplantation in patients with hepatocellular carcinoma (HCC) …
[HTML][HTML] Current management of hepatocellular carcinoma: an Eastern perspective
HJ Yim, SJ Suh, SH Um - World journal of gastroenterology: WJG, 2015 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death, especially in
Eastern areas. With advancements in diagnosis and treatment modalities for HCC, the …
Eastern areas. With advancements in diagnosis and treatment modalities for HCC, the …
Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising …
E Garin, L Lenoir, J Edeline, S Laffont… - European journal of …, 2013 - Springer
Purpose To evaluate the impact of dosimetry based on MAA SPECT/CT for the prediction of
response, toxicity and survival, and for treatment planning in patients with hepatocellular …
response, toxicity and survival, and for treatment planning in patients with hepatocellular …
Yttrium‐90 radioembolization vs sorafenib for intermediate‐locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis
A Gramenzi, R Golfieri, C Mosconi, A Cappelli… - Liver …, 2015 - Wiley Online Library
Abstract Background & Aims Sorafenib and transarterial 90Y‐radioembolization (TARE) are
possible treatments for Barcelona Clinic Liver Cancer (BCLC) intermediate‐advanced stage …
possible treatments for Barcelona Clinic Liver Cancer (BCLC) intermediate‐advanced stage …
Highly tumor-specific and long-acting iodine-131 microbeads for enhanced treatment of hepatocellular carcinoma with low-dose radio-chemoembolization
Y Qian, Q Liu, P Li, Y Han, J Zhang, J Xu, J Sun, A Wu… - ACS …, 2021 - ACS Publications
Transarterial radioembolization (TARE) is considered the standard treatment for
intermediate-stage hepatocellular carcinoma (HCC). Iodine-131 (131I)-labeled lipiodol …
intermediate-stage hepatocellular carcinoma (HCC). Iodine-131 (131I)-labeled lipiodol …
Quantitative and qualitative assessment of yttrium-90 PET/CT imaging
AA Attarwala, F Molina-Duran, KA Büsing… - PloS one, 2014 - journals.plos.org
Yttrium-90 is known to have a low positron emission decay of 32 ppm that may allow for
personalized dosimetry of liver cancer therapy with 90Y labeled microspheres. The aim of …
personalized dosimetry of liver cancer therapy with 90Y labeled microspheres. The aim of …
A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or sorafenib
MA de la Torre, J Buades‐Mateu… - Liver …, 2016 - Wiley Online Library
Abstract Background & Aims Sorafenib (SOR) is the standard of care for patients with
hepatocellular carcinoma (HCC) and portal vein invasion (PVI), based on the results of …
hepatocellular carcinoma (HCC) and portal vein invasion (PVI), based on the results of …
[HTML][HTML] Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives
JE Slotta, O Kollmar, V Ellenrieder… - World journal of …, 2015 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most common liver-derived malignancy with a high
fatality rate. Risk factors for the development of HCC have been identified and are clearly …
fatality rate. Risk factors for the development of HCC have been identified and are clearly …
Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein …
JS Zheng, J Long, B Sun, NN Lu, D Fang, LY Zhao… - Clinical radiology, 2014 - Elsevier
Aim To retrospectively assess long-term survival benefit and safety of transcatheter arterial
chemoembolization (TACE) combined with radiofrequency ablation (RFA) in hepatocellular …
chemoembolization (TACE) combined with radiofrequency ablation (RFA) in hepatocellular …
Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinoma
I Nel, HA Baba, J Ertle, F Weber, B Sitek… - Translational …, 2013 - Elsevier
Abstract BACKGROUND AND AIMS: Circulating tumor cells (CTCs) have been proposed as
a monitoring tool in patients with solid tumors. So far, automated approaches are challenged …
a monitoring tool in patients with solid tumors. So far, automated approaches are challenged …